Bernard Mach
Fondatore presso MaxiVAX SA
Posizioni attive di Bernard Mach
Società | Posizione | Inizio | Fine |
---|---|---|---|
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Direttore/Membro del Consiglio | 01/01/2005 | - |
Fondatore | 01/01/2005 | - |
Storia della carriera di Bernard Mach
Precedenti posizioni note di Bernard Mach
Società | Posizione | Inizio | Fine |
---|---|---|---|
LO FUNDS LIFE SCIENCES EXPERTISE | Fondatore | - | 28/03/2014 |
Corporate Officer/Principal | - | - | |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Direttore/Membro del Consiglio | 01/01/1997 | 17/01/2007 |
University of Geneva | Corporate Officer/Principal | - | 01/01/1998 |
NOVIMMUNE SA | Direttore/Membro del Consiglio | 27/04/2010 | - |
Fondatore | 27/04/2010 | - | |
LONZA GROUP AG | Direttore/Membro del Consiglio | - | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - |
Formazione di Bernard Mach
University of Geneva | Doctorate Degree |
The Rockefeller University | Doctorate Degree |
Statistiche
Distribuzione geografica
Svizzera | 7 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 5 |
Founder | 4 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
LONZA GROUP AG | Health Technology |
Aziende private | 5 |
---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
LO FUNDS LIFE SCIENCES EXPERTISE | Miscellaneous |
Novimmune SA
Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Commercial Services |
- Borsa valori
- Insiders
- Bernard Mach
- Esperienza